3Frohn C,Dumbgen L,Brand JM,et al.Probaility of anti-D development in D-ppatients receiving D+RBCs.Tranfusion,2003,43:893-898.
4Lo YMD,Corbetta N,Chamberlain,et al.Presence of fetal DNA in maternal plasma and serum[J].Lancet,1997,350(9076):485
5Lo YMD.Fetal RhD genotyping from maternal plasma[J].Ann Med,1999,31(2):308
6Lo YMD,Tein ASC,Lau TK,et al.Quantitative analysis of fetal DNA in maternal plasma and serum:implication for noninvasive prenatal diagnosis[J].Am J Hum Genet,1998,62(4):768
7van der Schoot CE,Tax GHM,Rijnders RJP,et al.Prenatal typing of Rh and Kell blood group system antigens:the adeg of a watershed[J].Transfusjon Med Rev,2003,17(1):31
8Lo YMD,Zhanf J,Leung TN,et al.Rapid clearance of fetal DNA from maternal plasma[J].Am J Hum Genet,1999,64(1):218
9Bianchi DW.Fetal cell in the maternal circulation:feasibility for prenatal diagnosis[J].Br J Haematal,1999,105(3):574
10van Wijk IJ,De Hoon AC,Jurhawan R,et al.Detection of apoptotic fetal cells in plasma of pregnantwomen[J].Clin Chem,2000,46 (3):729
1Slichter SJ, Kaufman RM, Assman SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage[J]. N Engl J Med,2010,362(7) 600-613.
3Heddle NM,Cook RJ ,Sigouin C,et al. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia [ J ]. Transfusion, 2006,46 (6) :903911.
4George T, Ho-Tin-Noe B. Carbo C, et al. Inflammation induces hellaorrhage in Thrombocytopenia [ J 1. Blood, 2008, 111(10) :4958-4964.
